← Back to Search

Allograft

MLG (Multi-Layered Perinatal Issue Allograft) Allograft for Postoperative Recovery

N/A

Waitlist Available

Led By Ram A Pathak, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up months 1, 3, 6, and 12

Awards & highlights

Study Summary

This trial will test if using human Umbilical Cord allograft can help improve return to erectile function and bladder control for patients who have had robot-assisted radical prostatectomy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ months 1, 3, 6, and 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~months 1, 3, 6, and 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and months 1, 3, 6, and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average time for return to continence

Average time for return to potency

Secondary outcome measures

Abdominal VAS (Visual Analog Scale) Pain Score

Costs of prescription

Expanded prostate cancer index composite-26 (EPIC-26) Score

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Umbilical Cord Allograft RecipientsExperimental Treatment1 Intervention

Male patients undergoing Robot Assisted Radical Prostectomy with bilateral nerve sparing technique will remain eligible to receive allograft during the surgery.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,239 Previous Clinical Trials

1,004,183 Total Patients Enrolled

Ram A Pathak, MDPrincipal InvestigatorAssistant Professor of Urology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age restriction of this clinical experiment capped at 45 years old?

"This trial is seeking participants aged between 30 and 65 years old."

Answered by AI

What key goals are investigators attempting to achieve through this investigation?

"The primary outcome of this medical trial, monitored for a year following the procedure, is Average time for return to continence. As secondary objectives, Abdominal VAS (Visual Analog Scale) Pain Score from 0-10 indicating no abdominal pain and 10 as worst will be surveyed; Value analysis of 25 historical SHIM-matched patients who underwent same surgery relative to baseline score in relation +4 points on total SHIM score; Return to potency signified by ability to achieve an erection sufficient for intercourse more than 50% of the time or at least 50% rigidity post-RARP; And EPIC-26 Score with five symptom"

Answered by AI

Would I qualify to enroll in this medical research program?

"Qualifying patients must have completed post-surgical recovery and be between 30 to 65 years old. In total, 25 individuals are needed for this trial."

Answered by AI

Are researchers currently looking for participants to join this trial?

"According to information posted on clinicaltrials.gov, this medical trial is no longer recruiting patients at present. The study was initially published in June of 2023 and the most recent update occurred November 28th 2022. Nevertheless, there are still 7 other trials currently enrolling subjects for research purposes."

Answered by AI